BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

RemeGen Secures FDA Clearance for Phase II Trials of Innovative Bispecific Antibody RC148 in Advanced Solid Tumors

RemeGen Co., announces clearance of IND application by Food and Drug Administration (FDA) for phase II clinical trials for its independently-developed bisp...

August 11, 2025 | News

Senhwa Advances CX-5461 into NCI-Sponsored Trial for MYC-Aberrant Lymphoma

Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious d...

August 08, 2025 | News

Astria Licenses HAE Drug Navenibart to Japan’s Kaken in $32M+ Deal

-- Up to $32 Million in Upfront and Milestone Payments, Plus Royalties -- -- Kaken Expertise in Commercializing Innovative Therapies Supports Navenibart...

August 08, 2025 | News

XtalPi and DoveTree Medicines Forge $5.99 Billion AI-Powered Drug Discovery Alliance

XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics for drug and materials discovery, announced ...

August 07, 2025 | News

“Spatial Biology at Scale: 10x Genomics CEO Serge Saxonov on Redefining Precision Medicine with TISHUMAP”

The future of medicine is being shaped at the intersection of spatial biology and artificial intelligence—and 10x Genomics is l...

August 07, 2025 | Interaction

Nebius Is Accelerating Drug Discovery with AI Infrastructure That Slashes Timelines from Years to Months

The traditional 7–10-year timeline for drug discovery is rapidly becoming obsolete. Thanks to advances in AI and compute infrastructure, pioneers lik...

August 04, 2025 | Interview

Chipscreen Biosciences Receives FDA IND Approval for Brain-Penetrant Aurora B Inhibitor CS231295

Shenzhen Chipscreen Biosciences Co., Ltd. ("Chipscreen Biosciences") announced that its wholly owned subsidiary, Chipscreen Biosciences (USA) Ltd., has rec...

August 04, 2025 | News

Atombeat and BioDuro Unite to Launch AI-Powered Platform for Next-Gen Peptide Drug Discovery

Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organizatio...

August 04, 2025 | News

Atombeat and BioDuro Unite to Launch AI-Powered Platform for Next-Gen Peptide Drug Discovery

Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organizatio...

August 04, 2025 | News

Mabwell’s CDH17-Targeting ADC 7MW4911 Receives IND Clearance in China and U.S.

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its proprietary CDH17-targeting antibody-drug ...

August 04, 2025 | News

Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Inhaled Microbiome Therapeutics

Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingh...

August 04, 2025 | News

Alphamab Oncology’s Bispecific ADC JSKN022 Clears IND Review in China

Alphamab Oncology announced that the Investigational New Drug (IND) application for JSKN022, an independently developed innovative bispecific antibody-drug...

August 04, 2025 | News

AGC Biologics Partners with Valneva to Advance Phase II Shigella Vaccine Supply from Heidelberg Site

AGC Biologics, your friendly CDMO expert, announced a development and manufacturing services agreement with specialty vaccine company Valneva SE ...

July 31, 2025 | News

BON Natural Life Launches AI-Powered Drug Discovery Platform, Advancing TCM-Based Pharma Innovation

Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading provider of bio-ingredient solutions for the natural health and personal care in...

July 31, 2025 | News

Stay Connected